Interestingly, it has been reported that TNBC, basal-like type breast cancer cell lines, relative to breast cancer cell lines representative of the other subtypes, exhibit a greater sensitivity to p42/44 MEK1/2 inhibitors [52, 53]. The gene discussed is MAP2K1; the disease is breast cancer.